Second-generation antipsychotics clinical pharmacy plan developed from hospital pharmacy to primary health care
Resumen: The growing role of hospital pharmacists in the ambulatory care setting challenges new changes. Drug distribution to Primary/Ambulatory Healthcare needs to reformulate
a clinical pharmacy practice plan when presented with a patient having schizophrenia, according to criteria of rational drug use, equity and accessibility of the patient for sustained concentrations for several weeks indicated only for chronic therapy in patients who have trouble adhering to oral therapy that might achieve a markedly decline of positive, negative and cognitive symptoms. Therefore, these important features of long-acting injectable antipsychotics (LAIs, previously known as depot antipsychotics) need to be addressed on real-world practice. The purpose of the study is to develop drug distribution logistics for second-generation antipsychotics from Spanish Hospital Pharmacy to all Primary Health Care Sector (target population: Urban, Rural, and Homecare Support) from 2015 to 2016.

Idioma: Inglés
DOI: 10.15406/ppij.2017.05.00126
Año: 2017
Publicado en: Pharmacy & Pharmacology International Journal 5, 4 (2017), [3 pp.]
ISSN: 2379-6367

Tipo y forma: Article (Published version)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Exportado de SIDERAL (2017-10-05-12:27:44)

Este artículo se encuentra en las siguientes colecciones:

 Record created 2017-10-05, last modified 2017-10-06

Versión publicada:
Rate this document:

Rate this document:
(Not yet reviewed)